© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

Treatment News

RNA strand
Scientists Are Working on mRNA Vaccines for HIV, Flu, Cancer and More
colored condoms
No, Using Condoms Doesn’t Mean You’re Smarter
2020 Top HIV Treatment Stories

FDA Approves Cabenuva, the First Complete Long-Acting Injectable HIV Treatment

Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.

Not All Women Are On Board With Injectable HIV Meds

Whether for treatment or prevention, women’s interest in injectable antiretrovirals varied based on their relationship with injection.

As People With HIV Age, Non-HIV Conditions Increase

At one Ryan White clinic in Virginia, the likelihood of multiple health conditions increased over time.

Unintended Pregnancy Associated With Higher HIV Viral Load

The findings highlight an ongoing need for better integration of HIV care with sexual and reproductive health care.

Tenofovir Levels Are Lower Among Trans Men on Hormones, but It May Not Impede PrEP

HIV prevention drugs don’t seem to impact gender-affirming hormone levels, but the opposite might not be true for trans men.

MUST read

Gene Editing Delays Viral Rebound During HIV Treatment Interruption
a US dollar symbol in a life preserver
Some People With HIV Don’t Adhere to Treatment to Save Money
There’s Never Been a Better Time to Get Pregnant If One of You Has HIV
POZ March 2019 cover U=U Undetectable = Untransmitable
Communicating Undetectable Equals Untransmittable
The Science Is Clear: With HIV, Undetectable Equals Untransmittable
4 in 5 HIV Transmissions Likely Come From Those Not in Care for the Virus
Human papillomavirus

Among People With HIV, Anal Warts Increase Likelihood of Anal Cancer by 13 Times

HPV-related anal or genital warts were linked to progression to cancer in a large, long-term study of people with HIV.
Novel coronavirus SARS-CoV-2

Large Clinical Trial Will Test Combination Monoclonal Antibody Therapy for Mild to Moderate COVID-19

The ACTIV-2 study aims to determine whether neutralizing antibodies reduce the duration of COVID-19 symptoms.

Injectable Contraceptives May Impact HIV Acquisition, but Only for Some Women

Contradicting a previous study, new data on injectable contraceptives suggest the vaginal microbiome may increase susceptibility to HIV.

People With HIV May Fare Better With Inflammatory Bowel Disease

People with HIV and ulcerative colitis or Crohn’s disease may need less IBD medication and have fewer hospitalizations.
Map of Washington, DC

DC’s Real-Time HIV Data Reveal Segregation, Options for Improving Care

Kenya has been using similar technology for three years. DC’s efforts are among the first in the United States.

Hot topics

#Cure
#Long-Term Survivors
Ounce of Prevention sign against a blue sky
#Prevention
PrEP written on a chalkboard
#PrEP

Many Primary Care Providers Still Don’t Understand PrEP

Nearly eight years after Truvada’s approval for HIV prevention, primary care providers struggle to understand—and prescribe—the pill.

U.S. Government Updates Pregnancy and Perinatal HIV Guidelines

PrEPception, breast feeding and HIV trial participation are front and center in updated federal guidelines.

In Scotland, PrEP Is Tied to Population-Level Decline in HIV

Researchers found that Truvada as pre-exposure prophylaxis greatly reduced HIV cases in both people on PrEP and those not on it.

HIV and COVID-19: What Do We Know Now?

Larger studies suggest people living with HIV might have a modestly higher risk of severe COVID-19, but much remains to be learned.
Advertisement
Features
Newsfeed

Hot topics

Forums: Support and discussion
Blogs: The community speaks
POZ Stories: Get inspired
Magazine: Search the archives
HIV: The Basics
Recursos de VIH/SIDA en Español
AIDS Is Everyday
Ask POZ